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THE conditions which govern the establishment and growth ofmultiple tumour
cell deposits in the affected animal are important in both experimental and clinical
situations. In the latter the removal or ablation ofa single tumour not infrequently
seems to initiate the appearance of new foci or an altered rate ofgrowth of other
remaining deposits. This applies particularly to the removal of a primary tumour
and the appearance and rate of growth of metastases. A similar experience has
been described in experimental tumour-host systems by Ehrlich (1908) and more
recently by others (Marie andClunet, 1910; Tyzzer, 1913; Schatten and Kramer,
1958). In experimental situations however, strict tumour-host immunological
compatibility seldom exists, and indeed a homologous relationship has applied to
much of the earlier experimental work dealing with this problem (see review by
Woglom, 1929). Also tumour inoculations usually have been made with solid
fragments, and the quantitative assessment of results is difficult.
In the present work cell titration techniques have been used in a homologous
tumour-host system to determine the number of cells required to induce 50 per
cent ofsingle tumours (ED50) in mice for both single (one leg) and double (two leg)
inoculations, and similarly the ED50 for the induction ofdouble tumours resulting
from double inoculations. Similar determinations of the various ED50 cell doses




Walter and Eliza Hall hybrid male mice weighing 30-40 g. were used as reci-
pient animals for tumour cell inoculations. Ehrlich ascites tumour, hyperdiploid
line ELD Lettre, 46 chromosomal mode was used. It had been passaged at weekly
intervals as an ascites growth in C3H strain mice for the past 4 years in these
laboratories. All experimental animals were housed in an air conditioned room
maintained at 20° ' 1°± C.
Tumour inoculations and titrations
A 5-7 day growth of ascites fluid was removed, a cell count was made on this
fluid using the eosin exclusion technique of Schrek according to Hoskins, Meynell
and Sanders (1956) to determine the viable cell index. Samples containing lessIMMUNOLOGICAL ATTENUATION AND HOMOGRAFTS
than 95 per cent viable cells were not used in titrations. Suitable dilutions ofthe
cells were made in ice coldTyrode solution to give doses of 101-104 cells per 0.2 ml.
of fluid for inoculation. Each inoculation (0-2 ml.) was made intramuscularly in
the thighs ofrecipient mice, just proximal to the knee joint.
Groups of mice received either a single inoculum (right or left leg) or a double
inoculum (both legs), as follows :-
Group A (unirradiated) . one leg (right or left) inoculated;
Group B (irradiated) . one leg (right or left) inoculated;
Group C (unirradiated) . both legs inoculated;
Group D (irradiated) . both legs inoculated.
In each group the mice were subdivided into six subgroups, each subgroup
consisting of 8-10 mice and six cell doses in the range 101-104 cells were used for
inoculation ofthe subgroup mice. In groups C and D both legs ofindividual mice
were inoculated with the same number of cells, but the doses varied amongst sub-
groups as for single inoculations.
Groups B and D mice received a mean dose of 450 rads whole body X-irradia-
tion, 24 hours preceding inoculation, using an X-ray source operated at constant
potential, the factors being 250 kV, 15 mA, 30 cm. FSD, 1 mm. Cu HVL and dose
rate in air of 300 r per minute. Animals were irradiated with maximum back
scatter provided by bolus packing and the doses calculated accordingly.
Analysis
The number of mice in each subgroup developing palpable tumour within six
weeks was scored. Mice dying during this period were excluded from the final
analysis. In this experiment no animal developed a tumour which spontaneously
regressed. An analysis was made (i) of the fractions of animals in each subgroup
of Groups A and B (single leg inoculations) which developed a tumour, (ii) the
fraction of mice in each subgroup of C and D (double leg inoculations) which
developed at least one tumour and (iii) the fractions in subgroups ofC and D which
developed two tumours (i.e. both limbs). Using the approximation method of
Finney(1952),probitswere calculated and a regression analysismadeofthetumour
incidence for the various groups. The mean inoculum cell dose (ED50) which
resulted in a 50 per cent incidence of tumours was calculated for each of the 4
groups.
RESULTS
The relevant regression equations, statistics and analysis of results for the
various groups are shown in Table I.
The findings indicate that for immunologically competent mice subjected to
the tumour homograft inoculation, the number of cells which had to be grafted
in each inoculum site to give a 50 per cent incidence of tumour bearing animals
(ED50) was not significantly different ifone or two inoculum sites (legs) were used,
namely, 282 and 355 cells respectively, although the animals inoculated in both
legs could be considered to have had an increased chance ofdeveloping one tumour,
since they received a total inoculum dose ofdouble the number of cells. However,
each cell inoculum has to be increased approximately tenfold (ED50 = 3162 cells)
for 50 per cent of animals inoculated in two legs to develop two tumours.
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TABLE I.-Tumour Incidence Following Single and Double Inoculations of Hybrid
Mice made with Ehrlich Ascites Tumour, with or without Previous Whole body
X-irradiation (450 rads). Analysis Based on the Probit Regression Y = m
(iSm)x + a
Group Regression Y= m (±Sm)x + a x2(n)t (P) ED50 (+SE) t (p)
A
(Unirradiated- . Y= 1.9(+0 11)x + 0.34 . 2-26 (6) . 282 4- 71*
single leg p= 0-65
inoculation)
B




(Unirradiated- . (i) Y= 1-3 (±0.16)x + 1-56 . 175 (4) 355 i 130*
double leg (one or more tumour per animal) p= 0.45
inoculation)
(ii) Y= 2-0 (±0 11)x - 2-00 . 4.96 (6) . 3162 ± 800 . 33
(two tumours per animal) p = 0.30 (p < 0.05)
D
(Irradiated- . (i) Y= 3-1 (+±00 9)x + 0-62 0-32 (3) . 24 + 5
double leg (one or more tumour per animal) p > 0 8
inoculation)
(ii) Y= 3-9 (±0*08)x - 1-*32 . 050 (3) . 42 ± 9 . 1*.2
(two tumours per animal) p > 0
- 7 (n.s.)
* Difference not significant (p = 0 6).
tThe statistic (X2(n) = (r nP): P) ) is used to determine heterogeneity of departure from the
fitted probit line.
Since the recipient mice were not preimmunised with the Ehrlich tumour anti-
gens, and since considerable cell multiplication and antigenic stimulation would
take place before significant antibody production could be expected, it was con-
sidered that these difference in the ED50 values could be attributed to quantitative
differences in development of the antigenic stimulus. To test this hypothesis, a
similar series of inoculations was made in recipient mice previously given whole
body X-irradiation (450 rads) to depress the immune response. It is seen that the
various ED50s were greatly reduced, and that the difference between single and
double tumours developing in mice which received two inoculations, was no
longer significant.
In Table II are shown the times of appearance of palpable tumours following
the inoculation of either 5 x 102 or 103 EAT cells in groups unirradiated and
irradiated recipients. It is seen that both single and double tumours appeared
earlier in the irradiated groups. In the mice which ultimately developed double
tumours, each of the two tumours appeared at much the same time and this
finding applied to both unirradiated and irradiated groups.
DISCUSSION
The results show that for tumour homografts the development or progression
of a single focus of tumour is clearly dependent on other cells ofthe same tumour
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TABLEII.-Incidence of Palpable Tumours Scored Weekly in Surviving Unirradi-
ated and Irradiated Mice after receiving either Single or Double Inoculations
of EAT cells. The Fraction of Mice with Palpable Tumours is Designated To
(no tumours), T1 (One Tumour only) and T2 (Two Tumours) respectively
Number Time after inoculation
EAT cells ,
inoculated 7 days 14 days 21 days 28 days
Unirradiated . 103 cells . To (10/10) To (7/10) To (2/10) To (3/10)
group in one leg T1 (3/10) T1 (8/10) T1 (7/10)
103 cells . To (10/10) To (8/10) To (1/9) To (0/9)
in each leg T1 (1/10) T1 (5/9) T1 (6/9)
T2 (1/10) T2 (3/9) T2 (3/9)
5 x 102 cells . To (10/10) To (10/10) To (7/10) To (3/10)
in one leg T1 (3/10) T1 (7/10)
5 X 102 cells . To (10/10) To (10/10) To (5/10) To (5/9)
in each leg T1 (4/10) T1 (3/9)
T2 (1/10) T2 (1/9)
Irradiated . 103 cells . To (9/9) To (0/8) T1 (8/8) T1 (8/8)
(500r) group in one leg T1 (8/8)
103 cells . To (9/9) To (0/9) T2 (8/8) T2 (7/7)
in each leg T1 (0/9)
T2 (9/9)
5 x 102 cells . To (8/8) To (0/6) T1 (6/6) T1 (6/6)
in one leg T1 (6/6)
5 x 102 cells . To (10/10) To (0/10) T2 (10/10) T2 (9/9)
in each leg T1 (0/10)
T2 (10/10)
being present and developing in the host animal at the same time. Furthermore
it would seem that this is a mechanism which is largely based on an immune
response, since the phenomenon disappears following depression (attenuation) of
the immunological response of the host animal by whole body irradiation. The
implications of this finding are of considerable importance to experimental tech-
niques used in oncology which depend on the establishment of multiple cell foci
following intravenous inoculation of cells as a method of simulating metastatic
spread. Whether a similar reservation applies to strictly isologous systems such
as that of Hewitt and Wilson (1959) is doubtful. However, a review of previously
reported results of cell titration in certain isologous systems, has shown that ED50
doses as high as 107 cells were reported (van den Brenk, 1961). The criticism
arises that immunological incompatibility may largely account for the magnitude
of such values. That whole body irradiation is a useful experimental expedient in
reducing the homograft reaction has been shown by recent studies (Mazurek and
Duplan, 1959; Cohen and Cohen, 1960; van den Brenk, 1961).
In helping to explain certain growth phenomena seen in human tumours, the
results of experimental animal studies need careful assessing in terms of homo-
graft reactions (Woglom, 1929). In the early work of Marie and Clunet (1910)
and Tyzzer (1913) who reported that partial excision of implanted tumours in
mice was followed by enhanced growth of metastases, homografts were used. In
the important studies of Schatten (1958) solid tumour transplants of melanoma
S-91 and DBA sarcoma 49 were made in either DBA or C x DBA hybrid mice.
Schatten showed that removal of such primary tumours resulted in the establish-
ment and rapid growth of large numbers of latent pulmonary metastases. This
phenomenon was not dependent on the surgical trauma (Schatten and Kramer,
1958) and was considered to show that "a primary tumour of sufficient size in-
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hibits the development and growth of its distant metastases ". Furthermore
Schatten considered that the "majority of the metastases in these tumour-host
systems would have been dormant or would have succumbed ifthe primary tumour
had not been removed ". It is unfortunate that immune reactions may have in-
fluenced these results. Similarly in experimental studies which claim to have shown
that irradiation of a primary tumour causes an increase in the development of
metastases (Kaplan and Murply, 1949; von Essen and Kaplan, 1952; Kaae,
1953), proper evaluation was not made of the effect of the irradiation on immuno-
logical compatibility, since the most careful local irradiations of tumours in small
animals, are accompanied by a substantial whole body dosage contribution (van
den Brenk, 1961). In the work of Olch, Eck and Smith (1959) the incidence of
pulmonary metastases following local irradiation of melanoma S-91 in hybrid
C x DBA mice with 3000 r was not consistently increased nor decreased. For a
hamster lymphosarcoma Greene (1959) reported that surgical removal of the
primary tumour was followed by an increased incidence of widespread metastases.
Biopsy or removal of normal tissue, per se, had no effect on metastases. On the
other hand Greene reported that for two transplants made in different sites, whilst
the one did not influence the growth of the other, two such growing tumours
actually reduced the incidence of metastases from 10 per cent to nil, and that
removal ofone ofthe two primary tumours raised the metastatic incidence to the
basal 10 per cent level for one tumour ! The results of experiments of Flintjer and
Mefferd (1960) using a transplantable fibrosarcoma in Sherman strain rats, are
difficult to assess, but in general demonstrate that viable tumour tissue, whether
it was implanted or not, caused resistance to further grafting in test animals.
In conclusion, the factors which determine the balance of growth rates for
multiple tumours in the same individual, seem to be of considerable importance to
both clinical and experimental studies. However the experimental approach to
the problem should particularly aim to control two critical factors, namely the
inoculation cell dosage and the tumour-host immunological relationship. Cell
titration techniques are considered desirable as distinct from solid tumour trans-
plants. Also, in isologous systems the determination ofED50 doses is essential and
immunological attenuation by whole body irradiation is an added safeguard in
evaluating the participation of immune reactions in the observations made. In
this way, humoral factors which are distinct from antigen-antibody reactions and
which influence the development and growth rate oftumours in the body, may be
demonstrated and their nature established. The results reported in this paper
suggest that for the tumour homograft studied, such balance of growth is largely
dependent on an immune reaction, and for this reason does not clarify the factors
which determine balance of growth in spontaneous human tumours. Similarly
the almost complete absence of data relating to ED50 values for the cells of spon-
taneous human tumours, greatly hampers the evaluation of similar factors in
humans in respect to both the natural history of the disease and its treatment by
radiotherapeutic and other means.
SUMMARY
Titration of hyperdiploid Ehrlich ascites tumour cells in mice as single leg
inoculations showed that 282 cells were required to induce 50 per cent of tumours
(ED50). When double leg inoculations were made, the ED50 for single tumour
development was 355 cells, and not significantly increased. However the cell
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dose required for inoculation of each leg for 50 per cent of the animals to develop
two tumours was increased tenfold to 3162 cells. Whole body X-irradiation of
mice preceding inoculation, to reduce the immune response greatly reduced the
ED50 value to <10 cells for single inoculations, whilst the ED50 doses for single
and double tumour establishment after double inoculations were 24 and 42 cells
respectively. These findings are discussed in relation to clinical and experimental
situations where the establishment and growth of multiple neoplastic foci inthe
single host are to be evaluated.
I am indebted to my technicians, Mrs. K. Elliott and Miss H. Hutchings for
their excellent assistance.
REFERENCES
VAN DEN BRENK, H. A. S.-(1961) Brit. J. Cancer, 15, 61.
COHEN, A. AND COHEN, L.-(1960) Nature, Lond., 185, 262.
EHRLICH, P.-(1908) Verhandl. deutsch. path. Gesellsch., 12, 13.
VON ESSEN, C. F. AND KAPLAN, H. S.-(1952) J. nat. Cancer Inst., 12, 883.
FINNEY, D. J.-(1952) 'Probit Analysis ', 2nd Edition. London (Cambridge University
Press).
FLINTJER, J. D. AND MEFFERD, R. B.-(1960) Cancer, 13, 172.
GREENE, H. S. N.-(1959) Proc. Amer. Ass. Cancer Res., 3, 124.
HEWITT, H. B. AND WILSON, C. W.-(1959) Nature, Lond., 183, 1060.
Hosms, J. M., MEYNELL, G. G. AND SANDERS, F. K.-(1956) Exp. Cell Res., 11, 297.
KAAE, S.-(1953) Cancer Res., 13, 744.
KAPLAN, H. S. AND MURPHY, E. D.-(1949) J. nat. Cancer Inst., 9, 407.
MARIE, P. AND CLUNET, J.-(1910) Bull. Ass. franv. Cancer, 3, 19.
MAZUREK, C. AND DUPLAN, J. F.-(1959) Ibid., 46, 119.
OLCH, P. D., ECK, R. V. AND SImI, R. R.-(1959) Cancer, 11, 460.
SCHATTEN, W. E.-(1958) Ibid., 11, 455.
Idem AND KRAMER, W. M.-(1958) Ibid., 11, 460.
TYZZER, E. E.-(1913) J. med. Res., 28, 309.
WOGLOM, W. H.-(1929) Cancer Rev., 4, 129.